Geneva, April 28 -- International Clinical Trials Registry received information related to the study (TCTR20260417013) titled 'Impact of Different Domperidone Dosages on Reflux Esophagitis Treated with Esomeprazole: A Randomized Controlled Trial' on April 17.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Beijing Hospital of Integrated Traditional Chinese and Western Medicine
Condition:
Reflux Esophagitis
Esomeprazole
Reflux esophagitis
Domperidone
Proton pump inhibitors
Esomeprazole
Reflux esophagitis
Domperidone
Proton pump inhibitors
Intervention:
The standard esomeprazole (Astrazeneca, National Drug Approval No. H20046380, 40mg per tablet) treatment is administered at a dose of 40mg once daily, 30 minute...